首页 | 官方网站   微博 | 高级检索  
     

万乃洛韦毫微粒对肝脏和肝细胞胞内靶向性的研究
引用本文:张志荣,何勤.万乃洛韦毫微粒对肝脏和肝细胞胞内靶向性的研究[J].中国医院药学杂志,1999,19(1):15-18.
作者姓名:张志荣  何勤
作者单位:华西医科大学药学院,成都610044
摘    要:目的:测定静注万乃洛韦聚氰基丙烯酸正丁酯毫微粒(VACVPBCANP)冻干剂和万乃洛韦小鼠体内的分布。方法:用体外肝细胞培养及摄取实验研究VACVPBCANP对肝细胞的胞内靶向性。结果:VACVPBCANP静注后15min即有74.49%的VACV集中在肝脏,比VACV注射液提高了2.99倍,肾脏分布量降低了5.46倍。结论:VACV制成毫微粒后可明显增加肝细胞的摄取量

关 键 词:万乃洛韦,肝靶向毫微粒给药系统,毫微粒体外细胞摄取

Study on liver and hepotocytes targeting of valaciclovir polybutyl cyanoacrylate nanoparticles
Zhang Zhirong,He Qin.Study on liver and hepotocytes targeting of valaciclovir polybutyl cyanoacrylate nanoparticles[J].Chinese Journal of Hospital Pharmacy,1999,19(1):15-18.
Authors:Zhang Zhirong  He Qin
Abstract:OBJECTIVE:To study the distribution of VACV PBCA NP in visceras of mice.METHODS:Uptake of hepotocytes was used to study the permeation of VACV PBCA NP cross the liver cell membrane.HPLC was used to determine the contents of ACV in visceras.RESULTS:The content of VACV PBCA NP in liver was found to be 74.79% of total amount 15 min after iv administration,which was 2.99 times higher than value of VACV injection.While content in kidney was 5.46 times lower than that of VACV in injection.The VACV PBCA NP was found in liver cell of mice by TEM method.CONCLUSIONS:The cell uptake by rat hepotocytes in vitro demonstrated that nanoparticles could greatly increase the amount of VACV uptaking by cell.
Keywords:valaciclovir  aciclovir nanoparticles  cell permeation
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号